Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events

Cited by (785)

Items 501–600 of 785

1. J-curve phenomenon: a matter of debate.
   Eirini Andrikou, Ioannis Bafakis, Charalampos A. Grassos, Anastasios Papaspyropoulos, ATHANASIOS J. KRANIDIS · 2012 · PubMed
2. ¿Puede el tratamiento de la hipertensión arterial ayudar a prevenir la demencia?
   Luis Castilla‐Guerra, María del Carmen Fernández‐Moreno, Jesús Álvarez Suero, María Dolores Jiménez-Hernández · 2013 · Revista de Neurología
3. Vascular Dementia and Cognitive Impairment
   Sudha S. Seshadri, Alexis Economos, Clinton B. Wright · 2015 · Elsevier eBooks
4. Cardiovascular Risk in Hypertension – Can We Ask for More?
   Massimo Volpe · 2008 · High Blood Pressure & Cardiovascular Prevention
5. Blockage of the Renin-Angiotensin System in the Secondary Prevention of Stroke: Beneficial Effects Beyond Blood Pressure Reduction?
   Luis Castilla‐Guerra, María del Carmen Fernández‐Moreno, María Dolores Jiménez-Hernández · 2009 · Stroke
6. Hypertension and Risk of Stroke: A Systematic Review and Meta-Analysis
   Ahmad Mohammad, Iti Yadav, Usman Ghani Lashari, Sarah Sabra, Adam Sabra, Mariam Sabra, Fatima Tariq, Jaisingh Rajput · 2025 · Cureus
7. Risks of dementia and stroke in patients with hypertension using telmisartan or other renin‑angiotensin system inhibitors
   Chi‐Hung Liu, Ming‐Lung Tsai, Ning‐I Yang, Ting-Yu Chang, Tien‐Hsing Chen, Yi‐Chia Wei · 2026 · Alzheimer s & Dementia
8. Evidence-based carotid artery–based interventions for stroke risk reduction
   Charles Keith Ozaki, Piotr S. Sobieszczyk, Karen J. Ho, James T. McPhee, Edwin Charles Gravereaux · 2014 · Current Problems in Surgery
9. Angiotensin II Receptor Blockers and Risk of Cancer: Cause for Concern?
   Frederic F. Rahbari-Oskoui · 2010 · American Journal of Kidney Diseases
10. Impact of telmisartan in modifying vascular risk
    Jean-Philippe Baguet · 2010 · Integrated Blood Pressure Control
11. Chronic kidney disease and stroke: more observations but no trials
    Adrian Constantin Covic, Luminita E. Voroneanu · 2017 · Nephrology Dialysis Transplantation
12. Effect of renin-angiotensin-aldosterone system inhibitors on all-cause mortality and major cardiovascular events in patients with diabetes: A meta-analysis focusing on the number needed to treat and minimal clinical effect
    Xiaochun Yang, Li-Li Shao, Ying-Jun Mi, Wenhao Zhang, Nuo-Ya Liu, Ruo-Bin Liu, Xiaoxi Zhou, Weihong Zhang, Qing‐Bao Tian · 2020 · Journal of Diabetes and its Complications
13. Association between angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers and community‐acquired pneumonia: A nationwide population propensity‐score matching study
    Shih‐Yi Lin, Shih‐Sheng Chang, Cheng‐Li Lin, Cheng‐Chieh Lin, Wu‐Huei Hsu, Chia-Hui Chou, Chih‐Yu Chi, Chia‐Der Lin, Chih‐Yen Tu, Chung Y. Hsu et al. · 2021 · International Journal of Clinical Practice
14. Antihypertensive Drugs
    Matthew R. Weir, Donna S. Hanes, David K. Klassen · 2012 · Elsevier eBooks
15. Vascular Dementia and Cognitive Impairment
    Sudha S. Seshadri, Michelle R. Caunca, Tatjana Rundek · 2021 · Elsevier eBooks
16. Superior stroke prevention with angiotensin receptor blockers compared with other antihypertensive drugs
    Steven G. Chrysant · 2023 · Expert Opinion on Drug Safety
17. Prognostic impact of optimal lifestyle advice and medical therapy in patients with peripheral arterial disease
    Daniel Košuta, Urška Hvala, Zlatko Fras, Borut Jug · 2023 · VASA
18. Recent evidence on target blood pressure in patients with hypertension
    Hack‐Lyoung Kim · 2024 · Cardiovascular Prevention and Pharmacotherapy
19. Blood Pressure and Prevention of Stroke
    Katarina B. Dakay, Brian Silver · 2017 · Seminars in Neurology
20. A Cross-sectional Study on Awareness regarding Animal Bite Wound Management and Rabies Immunization among Students of a School of Nursing in a City of India
    Hari S Joshi, Arun Singh, Deepak Upadhyay, Sudeepti Panat · 2017 · International Journal of Advanced and Integrated Medical Sciences
21. Does the Naked Emperor Parable Apply to Current Perceptions of the Contribution of Renin Angiotensin System Inhibition in Hypertension?
    Carlos Maria Ferrario, Amit K. Saha, Jessica L. VonCannon, Wayne J. Meredith, Sarfaraz Ahmad · 2022 · Current Hypertension Reports
22. Blood Pressure Control and Primary Prevention of Stroke: Summary of Clinical Trial Data
    W.J. Elliott · 2010 · Humana Press eBooks
23. Hitting the Mark: Blood Pressure Targets and Agents in Those With Prevalent Cardiovascular Disease and Heart Failure
    Dena E. Rifkin, Michael S. Kiernan, Mark J. Sarnak · 2015 · Advances in Chronic Kidney Disease
24. Impact of recent landmark clinical trials on hypertension treatment
    Ikechi Gareth Okpechi, Brian Lindsay Rayner · 2011 · Clinical Investigation
25. ABCD2 Score May Discriminate Minor Stroke from TIA on Patient Admission
    Hui Zhao, Qingjie Li, Mengru Lu, Yuan Shao, Jingwei Li, Yun Xu · 2013 · Translational Stroke Research
26. Angiotensin Receptor Blockers and Tumorigenesis: Something To Be (or Not To Be) Concerned About?
    Vadim Tchaikovski, Gregory Y.H. Lip · 2012 · Current Hypertension Reports
27. The COSEHC™ Global Vascular Risk Management quality improvement program: first follow-up report
    Carlos Maria Ferrario, Joyner, Chris Colby, Alex Exuzides, Moore, Simmons, Bestermann, Frech-Tamas · 2013 · Vascular Health and Risk Management
28. Antithrombotic selection and risk factor management in ischemic stroke and transient ischemic attack
    Brian S. Katz, Kelly D. Flemming · 2014 · Neurosurgical FOCUS
29. Influence of angiotensin-converting enzyme insertion/deletion polymorphism on nitric oxide production in hypertensives and hypercholesterolaemics
    Shanyang He, Huiling Huang, Shuangquan Tan, Xiaodong Fu, Lei Su, D. X. Peng, R. J. Lin, Ka Sing Wong · 2010 · Journal of Clinical Pharmacy and Therapeutics
30. Treatment strategies to prevent stroke: focus on optimal lipid and blood pressure control
    Vasilios Papademetriou, Michael N. Doumas · 2009 · Expert Opinion on Pharmacotherapy
31. Hemmstoffe des Renin-Angiotensin-Systems
    Franz Weber, Manfred Anlauf · 2017 · Springer eBooks
32. Hypertension Guidelines: A Major Reappraisal Critically Examines the Available Evidence
    Michael A. Weber, Barry J. Materson · 2010 · Journal of Clinical Hypertension
33. Use of Renin-Angiotensin System Blockade in Patients with Renal Artery Stenosis
    Jordana B. Cohen, Raymond R. Townsend · 2014 · Clinical Journal of the American Society of Nephrology
34. Optimizing prevention and guideline-concordant care in Montenegro
    Božidarka Knežević, Ljilja Musić, Goran Batrićević, Aneta Bošković, Nebojša Bulatović, Ana Nenezić, Jelena Vujović, Milovan Kalezić · 2016 · International Journal of Cardiology
35. Blood Pressure Lowering for the Secondary Prevention of Stroke
    Shunsuke Funakoshi, Miki Kawazoe, Kazuhiro Tada, Makiko Abe, Hisatomi Arima · 2022 · Cardiology Discovery
36. Arterielle Hypertonie
    Thomas Eschenhagen A, Joachim Weil · 2022 · Springer eBooks
37. Angiotensin Receptor Blockers Should Be Regarded as First-Line Drugs for Stroke Prevention in Both Primary and Secondary Prevention Settings
    Daniel G. Hackam · 2009 · Stroke
38. Prevention of major cardiovascular events with an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker early or late after stroke
    W. Van Mieghem · 2009 · Journal of Hypertension
39. ACE Inhibitors and Angiotensin Receptor Blockers for the Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus
    Neil R Poulter · 2025 · Cardiology and Therapy
40. Blood Pressure Management in Neurologic Emergencies
    Holden M. Wagstaff, Holly K. Ledyard · 2025 · Emergency Medicine Clinics of North America
41. Comparative effectiveness of telmisartan vs. other angiotensin receptor blockers in reducing hypertension-related cerebrovascular and cardiovascular events: a real-world retrospective study using the TriNetX network
    Tse-Yu Chen, Yi-Chun Lin, Guang‐Yaw Liu, Hui‐Chih Hung · 2026 · Frontiers in Cardiovascular Medicine
42. Prävention des Schlaganfalls
    Stephan Lüders, Joachim Schrader · 2009 · Der Internist
43. Prevention of Second Strokes Through Blood Pressure Lowering: Update for 2011
    Dilip K. Pandey, Venkatesh Aiyagari · 2011 · Current Cardiovascular Risk Reports
44. The Appropriate Interpretation of Recent Clinical Trials -How to Read RCT in the Era of Advertizing-based Medicine-
    Iwao Kuwajima · 2011 · Journal of the Korean Society of Hypertension
45. Significant beneficial effect of AT-1 receptor blockers (sartans) in stroke
    Marwan S.M. Al-Nimer · 2012 · Neurosciences
46. A Comparative Study of Olmesartan and Valsartan on Insulin Sensitivity in Hypertensive Patients with Diabetes Mellitus or Impaired Glucose Tolerance (OVIS Study)
    Sadatoshi Biro · 2014 · Clinical Pharmacology & Biopharmaceutics
47. Sensorineural Hearing Loss in Adults: Etiological Study
    Saurabh Varshney, Sanjeev Bhagat, Sampan Singh Bist, Shishir Gupta · 2017 · International Journal of Advanced and Integrated Medical Sciences
48. Sartans in the treatment of arterial hypertension: focus on telmisartan and azilsartan. A review
    Закиев Вадим Дмитриевич, Yu. V. Kotovskaya, О. Н. Ткачева · 2023 · Terapevticheskii arkhiv
49. Oral Motor Disorders And Speech Disorders As Risk Factors For Difficulty Eating In Children Aged 6-60 Months
    Audi Yudhasmara, Asrini Kaninta Adani, Ida Narulita Dewi, Widodo Judarwanto, Sandiaz Yudhasmara · 2024 · Journal of Social Science (JoSS)
50. Blood Pressure Control Among Diabetic Patients in the Eastern Mediterranean Region: A Systematic Review and Meta-Analysis
    Amir Hossein Behnoush, Sepehr Khosravi, Fateme Ziamanesh, Rasha Atlasi, Ali Sheidaei, Negin Sanadgol, Amirmohammad Khalaji, Ozra Tabatabaei‐Malazy, Afshin Ostovar · 2024 · Current Diabetes Reviews
51. Dementia and management of vascular cognitive impairment
    Olivier Godefroy · 2013 · Cambridge University Press eBooks
52. Therapeutic strategies and neurorehabilitation
    Michael Brainin, Wolf‐Dieter Heiss · 2014 · Cambridge University Press eBooks
53. Are the effects of blood pressure lowering treatment diminishing?: meta-regression analyses
    Yoichi Sekizawa, Yoko Konishi, Moriyo Kimura · 2018 · Clinical Hypertension
54. Angiotensin receptor blockers: rational prescription tailored to the cardiovascular risk and comorbidities
    Valery I. Podzolkov, Писарев Михаил Владимирович, D. A. Zateyshchikova · 2018 · Russian Journal of Cardiology
55. Treatment
    Louis R. Caplan · 2009 · Elsevier eBooks
56. Hypertonologie 2007–2008
    Christos Chatzikyrkou, Jan Menne, Hermann G. Haller · 2009 · Medizinische Klinik - Intensivmedizin und Notfallmedizin
57. Inhibition of the Renin-Angiotensin-Aldosterone System for Cerebrorenal Protection
    Hiddo J.L. Heerspink · 2013 · Contributions to nephrology
58. Combination Therapy in Hypertension
    Anna Solini, José Antonio García‐Donaire, Luis Miguel Ruilope · 2012 · Current Cardiovascular Risk Reports
59. Choosing the ideal drug for hypertension after ischemic stroke
    Eduard Rozner, Arnold E. Eggers, Daniel M. Rosenbaum · 2009 · Current Hypertension Reports
60. Is reduction of blood pressure in acute stroke justified?
    Philip B. Gorelick · 2011 · The Lancet Neurology
61. Cardio classics revisited – focus on the role of candesartan
    Maria Leonarda De Rosa · 2010 · Vascular Health and Risk Management
62. Establishing Targets for Hypertension Control in Patients with Comorbidities
    Carlos A. Feldstein, Stevo Julius · 2010 · Current Hypertension Reports
63. Angiotensin Receptor Blockers, Cancer, and Smoking
    Iñaki Marina, Lawrence R. Krakoff · 2010 · Journal of Clinical Hypertension
64. Do we need more long-term outcome trials for the treatment of hypertension?
    D. Gareth Beevers, Gordon T McInnes · 2011 · The Journal of the Royal College of Physicians of Edinburgh
65. Prevención secundaria del ictus isquémico no cardioembólico
    Pedro Armario, Xavier Pintó, Cristina Soler, Pere Cardona · 2015 · Clínica e Investigación en Arteriosclerosis
66. Drug-Eluting versus Bare-Metal Stents in Acute Myocardial Infarction
    Brian Y L Wong · 2009 · New England Journal of Medicine
67. Lost to Follow-up and Withdrawal of Consent in Contemporary Global Cardiovascular Randomized Clinical Trials
    Fátima Rodríguez, Robert W. Harrison, DANIEL M. WOJDYLA, Kenneth W. Mahaffey · 2015 · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine
68. Developments in Secondary Stroke Prevention
    Hans‐Christoph Diener, Patrick Wong · 2008 · European Neurological Review
69. Secondary Stroke Prevention
    Mónica Doménech, Miguel Camafort, António Coca · 2016 · Updates in hypertension and cardiovascular protection
70. Telmisartan: clinical evidence across the cardiovascular and renal disease continuum
    Piyush M. Patel · 2016 · Drugs & Therapy Perspectives
71. Capítulo 8 - Hipertensão e Condições Clínicas Associadas
    Marcus Vinícius Bolívar Malachias, WKSB Souza, Frida Liane Plavnik, CIS Rodrigues, AA Brandão, Mário Fritsch Neves, Luiz Aparecido Bortolotto, RJS Franco, CEP Figueiredo, PCBV Jardim et al. · 2016 · Arquivos Brasileiros de Cardiologia
72. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial
    Sang‐Ho Jo, Sung‐Ji Park, Eung Ju Kim, Soo–Joong Kim, Hyun-Jae Cho, Jong‐Min Song, Jinho Shin, Jin Joo Park, Joon‐Han Shin, Kyoo‐Rok Han et al. · 2018 · Trials
73. Clinical Profile of Refractive Errors in School-going Children of Bareilly, Uttar Pradesh, India
    Ritu Jain, Juhi Mittal, Yusuf Rizvi · 2017 · International Journal of Advanced and Integrated Medical Sciences
74. Biomedical Waste Management Rules, 2016: A Brief Review
    Arun Singh, Hari S Joshi, Rashmi Katyal, Rashmi Singh, Himalaya Singh · 2017 · International Journal of Advanced and Integrated Medical Sciences
75. Prevalence of coronary risk factors in load transport drivers
    Beatriz Bastos Braga, Fabrícia Geralda Ferreira, Hamilton Henrique Teixeira Reis, João Carlos Bouzas Marins · 2022 · Revista Brasileira de Medicina do Trabalho
76. Postoperative alterations in ventriculoarterial coupling are an indicator of cardiovascular outcomes in liver transplant recipients
    Ji Yeon Kim, Young‐Jin Moon, Changjin Lee, Jin Ho Kim, Junghyun Park, Jung-Won Kim · 2023 · Korean Journal of Anesthesiology
77. Lower aldosterone–renin ratio is a risk factor for total and cancer death in Japanese individuals: the Takahata study
    Makoto Daimon, Tsuneo Konta, Toshihide Oizumi, Wataru Kameda, Shinji Susa, Ken Terui, Takeshi Nigawara, Kazunori Kageyama, Yoshiyuki Ueno, Isao Kubota et al. · 2014 · Clinical Endocrinology
78. Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
    M. GABRIEL KHAN · 2014 · Contemporary cardiology
79. TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS
    Малай Людмила Николаевна, A. N. Miroshnichenko, B. V. Sharykin, V. V. Konurovsky · 2009 · Rational Pharmacotherapy in Cardiology
80. The Changing Effect of Blood Pressure on Stroke Outcomes Through Acute to Subacute Stage of Ischemic Stroke
    Jihoon Kang, Beom Joon Kim, Moon‐Ku Han, Hee‐Joon Bae · 2019 · Journal of Stroke and Cerebrovascular Diseases
81. Revival of beta-blockers in arterial hypertension
    Cristiana Vitale, Ferdinando Iellamo, Maurizio Volterrani · 2012 · International Journal of Cardiology
82. ONTARGET, TRANSCEND and PROFESS – Clarifying, confusing or misleading
    Suzanne Oparil, Sverre Erik Kjeldsen, Thomas Hedner, Krzysztof Narkiewicz · 2009 · Blood Pressure
83. Perindopril for improving cardiovascular events
    James J. DiNicolantonio, James Henry O’Keefe · 2014 · Vascular Health and Risk Management
84. Lowering blood pressure in acute stroke: lessons learnt from the SCAST trial
    Philip M. Bath, Sandeep Ankolekar · 2011 · Expert Review of Neurotherapeutics
85. Telmisartan for Prevention of Cardiovascular Events
    Michael N. Doumas, Vasilios Papademetriou · 2009 · New England Journal of Medicine
86. A IMPORTÂNCIA DO CONTROLE PRESSÓRICO E ALCANCE DE METAS PRESSÓRICAS INTENSIVAS EM PACIENTES DIABÉTICOS E EM PACIENTES COM ACIDENTE VASCULAR CEREBRAL: OS ESTUDOS OPTIMAL-DIABETES E OPTIMAL-STROKE
    Karla Santo, Gisele Sampaio, Otavio B Berwanger · 2023 · Revista Brasileira de Hipertensão
87. Optimizing benefits of intensive SBP control in type 2 diabetes: the crucial role of angiotensin-converting enzyme inhibitors/angiotensin-II type 2 receptor blockers
    Rui-Ting Lin, Jing‐Wei Gao, Yong-Cong Yang, Xue-Wen Chen, Zhen-Jie Gu, Lei-Gang Tian, Zhe-Lin Chen, Lingyu Zhang · 2025 · Journal of Hypertension
88. A Multispecialty Consensus on Individualized Treatment Strategies for Hypertension Phenotypes and Comorbidities
    Gurpreet Singh Wander, Kamlesh Tewary, Arumugam Muruganathan, Agam C Vora, Girish Mathur, Chandramohan Meenakshisundaram, Narinder Pal Singh, Anup Barman, Munish Prabhakar, Nandini Chatterjee et al. · 2025 · Journal of the Association of Physicians of India
89. Optimizing blood pressure control in multimorbid hypertensive patients: insights from a real-world taiwanese cohort
    Shao-Kai Sum, Yu‐Yen Ou, Yao-Chang Wang, Tzu-Ping Chen, Shao‐Wei Chen, Chi‐Hsiao Yeh · 2025 · Journal of Hypertension
90. Efficacy of Renin Angiotensin Aldosterone System Inhibitors on Cardiovascular Outcomes in Hypertensive Population: A Network Meta-analysis of Randomized Controlled Trials
    Yueming Jiang, Jinbo Hu, Xiaoyan Yi, Qifu Li, Shumin Yang · 2026 · Drugs
91. Time is brain: an expanded concept, not only for ischemic stroke A viewpoint of the Italian Association for Emergency Neurology (ANEU)
    Marialuisa Zedde, Massimo Del Sette, R. Quatrale, Giovanni Cossu, Francesca Romana Pezzella, Giuseppe Micieli, Pietro Cortelli, Claudio Gasperini, Rosario Pascarella · 2026 · Neurological Sciences
92. Optimising blood pressure control after stroke: established wisdom and new frontiers
    Sonali Rukshana Gnanenthiran, Lili Song, Anthony Rodgers, Craig S. Anderson · 2026 · The Lancet Neurology
93. Should we change the target blood pressure in diabetic patients?
    Gadi Shlomai, Ehud Grossman · 2012 · Diabetes/Metabolism Research and Reviews
94. Blutdruck Zielwerte auf dem Prüfstand
    Jörg Slany · 2011 · Wiener klinische Wochenschrift
95. Antihypertensive Therapy Benefits: Pleiotropic Versus Blood Pressure-Dependent Mechanisms
    Sverre Erik Kjeldsen, Gordon T. McInnes · 2012 · Springer eBooks
96. Residual Risk in Treated Hypertension
    Alberto Zanchetti · 2012 · Springer eBooks
97. Relación entre hipertensión arterial y la demencia
    L. Reig-Puig, I. Antón-Rodrigo, Pau Sánchez Ferrín · 2011 · Hipertensión y Riesgo Vascular
98. Angiotensin receptor blockers and secondary stroke prevention: the MOSES study
    Dar D Dowlatshahi, Michael D. Hill · 2009 · Expert Review of Cardiovascular Therapy
99. Response to Letter by Castilla-Guerra et al
    Graeme J. Hankey · 2009 · Stroke
100. Angiotensin receptor blockers in preventing stroke: A systematic review and meta-analysis of randomized controlled trials
     Yanbing Duan · 2012 · African Journal of Pharmacy and Pharmacology